New York, NY, United States of America

Telomerase Activation Sciences, Inc.


USPTO Granted Patents = 4


Trademarks = 9

Forward Citations = 11

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Calvin B Harley (4 out of 47 patents)

silverMedal Premchandran H Ramiya (3 out of 9 patents)

bronzeMedal Mahesh Ramaseshan (3 out of 11 patents)

4.  Soo-Peang Khor (3 out of 8 patents)

5.  Steven Fauce (3 out of 3 patents)

6.  Tong Lin (3 out of 5 patents)

7.  Zhu Zhen Pirot (3 out of 5 patents)

8.  Tsutomu Akama (1 out of 59 patents)

9.  Allison C Chin (1 out of 6 patents)

10.  Nancy Yuk-yu Ip (1 out of 3 patents)

11.  Yung-hou Wong (1 out of 3 patents)

12.  David M Miller-Martini (1 out of 3 patents)

13.  Nancy Yuk-Yu Ip (13 patents)

14.  Yung-Hou Wong (0 patent)

15.  Calvin B Halrley (0 patent)


4 patents:

Company Overview
Telomerase Activation Sciences, Inc. is a biotechnology company focused on developing and commercializing products that enhance telomere biology. Our patented technology aims to support healthy aging and improve overall wellness by activating telomerase, an enzyme that plays a key role in maintaining telomere length. Visit our website to learn more about our groundbreaking research and products.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#1,393 in New York, NY

#3,678 in New York

#60,597 in US

New York, NY (US)
New York, NY, United States of America
Forward Citations = 11

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Telomerase Activation Sciences, Inc.. Retrieved from https://idiyas.com/company/telomerase-activation-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…